The preliminary evaluation on cholesterol-modified pullulan as a drug nanocarrier

References

• Akiyoshi K, Deguchi S, Moriguchi N, et al. (1993). Self-aggregates of hydrophobized polysaccharides in water. Formation and characteristics of nanoparticles. Macromolecules 26:3062–8
   Web of Science ®Google Scholar
• Akiyoshi K, Kobayashi S, Shichibe S, et al. (1998). Self-assembled hydrogel nanoparticle of cholesterol-bearing pullulan as a carrier of protein drugs: Complexation and stabilization of insulin. J Control Rel 54:313–20
   PubMed Web of Science ®Google Scholar
• Asayama W, Sawada S, Taguchi H, Akiyoshi K. (2008). Comparison of refolding activities between nanogel artificial chaperone and GroEL systems. Int J Biol Macromol 42:241–6
   PubMed Web of Science ®Google Scholar
• Fischer HC, Chan WCW. (2007). Nanotoxicity: the growing need for in vivo study. Curr Opin Biotechnol 18:565–71
   PubMed Web of Science ®Google Scholar
• Gonçalves C, Torrado E, Martins T, et al. (2010). Dextrin nanoparticles: studies on the interaction with murine macrophages and blood clearance. Coll Surf B: Biointerf 75:483–9
   PubMed Web of Science ®Google Scholar
• Gustafson DL, Rastatter JC, Colombo T, Long ME. (2002). Doxorubicin pharmacokinetics: macromolecule binding, metabolism, and excretion in the context of a physiologic model. J Pharmaceut Sci 91:1488–501
   PubMed Web of Science ®Google Scholar
• Herkenne C, Alberti I, Naik A, et al. (2008). In vivo methods for the assessment of topical drug bioavailability. Pharmaceut Res 25:87–103
   PubMed Web of Science ®Google Scholar
• Ikuta Y, Katayama N, Wang L, et al. (2002). Presentation of a major histocompatibility complex class 1–binding peptide by monocyte-derived dendritic cells incorporating hydrophobized polysaccharide–truncated HER2 protein complex: implications for a polyvalent immuno-cell therapy. Blood 99:3717–24
   PubMed Web of Science ®Google Scholar
• Jeong YI, Kim SH, Jung TY, et al. (2006). Polyion complex micelles composed of all-trans retinoic acid and poly (ethylene glycol)-grafted-chitosan. J Pharmaceut Sci 95:2348–60
   PubMed Web of Science ®Google Scholar
• Kim JH, Li Y, Kim MS, et al. (2012). Synthesis and evaluation of biotin-conjugated pH-responsive polymeric micelles as drug carriers. Int J Pharmaceut 427:435–42
   PubMed Web of Science ®Google Scholar
• Landsiedel R, Ma-Hock L, Kroll A, et al. (2010). Testing metal-oxide nanomaterials for human safety. Adv Mater 22:2601–27
   PubMed Web of Science ®Google Scholar
• Leathers TD. (2003). Biotechnological production and applications of pullulan. Appl Microbiol Biotechnol 62:468–73
   PubMed Web of Science ®Google Scholar
• Lee SJ, Hong GY, Jeong YI, et al. (2012). Paclitaxel-incorporated nanoparticles of hydrophobized polysaccharide and their antitumor activity. Int J Pharmaceut 433:121–8
   PubMed Web of Science ®Google Scholar
• Levchenko TS, Rammohan R, Lukyanov AN, et al. (2002). Liposome clearance in mice: the effect of a separate and combined presence of surface charge and polymer coating. Int J Pharmaceut 240:95–102
   PubMed Web of Science ®Google Scholar
• Li L, Gao FP, Tang HB, et al. (2010). Self-assembled nanoparticles of cholesterol-conjugated carboxymethyl curdlan as a novel carrier of epirubicin. Nanotechnology 21:265601 (11pp)
   Google Scholar
• Li SD, Huang L. (2008). Pharmacokinetics and biodistribution of nanoparticles. Mol Pharmaceut 5:496–504
   PubMed Web of Science ®Google Scholar
• Liu Z, Jiao Y, Wang Y, et al. (2008). Polysaccharides-based nanoparticles as drug delivery systems. Adv Drug Deliv Rev 60:1650–62
   PubMed Web of Science ®Google Scholar
• Lourenco C, Teixeira M, Simões S, Gaspar R. (1996). Steric stabilization of nanoparticles: size and surface properties. Int J Pharmaceut 138:1–12
   Web of Science ®Google Scholar
• Moghimi SM, Hunter A, Andresen T. (2012). Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective. Ann Rev Pharmacol Toxicol 52:481–503
   PubMed Web of Science ®Google Scholar
• Nel A, Xia T, Mädler L, Li N. (2006). Toxic potential of materials at the nanolevel. Science 311:622–7
   PubMed Web of Science ®Google Scholar
• Nomura Y, Ikeda M, Yamaguchi N, et al. (2003). Protein refolding assisted by self-assembled nanogels as novel artificial molecular chaperone. FEBS Lett 553:271–6
   PubMed Web of Science ®Google Scholar
• Pavlin M, Bregar VB. (2012). Stability of nanoparticle suspensions in different biologically relevant media. Dig J Nanomater Bios 7:1389–400
   Web of Science ®Google Scholar
• Shimoda A, Yamamoto Y, Sawada SI, Akiyoshi K. (2012). Biodegradable nanogel-integrated hydrogels for sustained protein delivery. Macromol Res 20:266–70
   Web of Science ®Google Scholar
• Simakov S, Tsur Y. (2007). Surface Stabilization of nano-sized titanium dioxide: improving the colloidal stability and the sintering morphology. J Nanoparticle Res 9:403–17
   Web of Science ®Google Scholar
• Singh RS, Saini GK, Kennedy JF. (2008). Pullulan: Microbial sources, production and applications. Carbohydr Polym 73:515–31
   PubMed Web of Science ®Google Scholar
• Sivakumar PA, Panduranga Rao K. (2003). The use of cholesteryl pullulan for the preparation of stable vincristine liposomes. Carbohydr Polym 51:327–32
   Web of Science ®Google Scholar
• Sonaje K, Lin YH, Juang JH, et al. (2009). In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery. Biomaterials 30:2329–39
   PubMed Web of Science ®Google Scholar
• Sunamoto J, Ushio K, Lai DT. (2006). Folate-modified cholesterol-bearing pullulan, a new cancer-targeted nanoparticle drug carrier: synthesis and applications. J Bioactive Compatible Polym 21:603–17
   Web of Science ®Google Scholar
• Tao X, Zhang Q, Ling K, et al. (2012a). Effect of pullulan nanoparticle surface charges on HSA complexation and drug release behavior of HSA-bound nanoparticles. PloS One 7:e49304 (13pp)
   Google Scholar
• Tao X, Zhang Q, Yang W, Zhang Q. (2012b). The interaction between human serum albumin and cholesterol-modified pullulan nanoparticle. Curr Nanosci 8:830–7
   Web of Science ®Google Scholar
• Vega-Villa KR, Takemoto JK, Yáñez JA, et al. (2008). Clinical toxicities of nanocarrier systems. Adv Drug Deliv Rev 60:929–38
   PubMed Web of Science ®Google Scholar
• Wang YS, Jiang Q, Li RR, et al. (2008). Self-assembled nanoparticles of cholesterol-modified O-carboxymethyl chitosan as a novel carrier for paclitaxel. Nanotechnology 19:145101 (8pp)
   Google Scholar
• Yang WZ, Chen HL, Gao FP, et al. (2010). Self-aggregated nanoparticles of cholesterol-modified pullulan conjugate as a novel carrier of mitoxantronep. Curr Nanosci 6:298–306
   Web of Science ®Google Scholar
• Yang W, Wang M, Ma L, et al. (2014). Synthesis and characterization of biotin modified cholesteryl pullulan as a novel anticancer drug carrier. Carbohydr Polym 99:720–7
   PubMed Web of Science ®Google Scholar
• Yoksan R, Chirachanchai S. (2008). Amphiphilic chitosan nanosphere: studies on formation, toxicity, and guest molecule incorporation. Bioorganic Med Chem 16:2687–96
   PubMed Web of Science ®Google Scholar
• Zhang HZ, Gao FP, Liu LR, et al. (2009). Pullulan acetate nanoparticles prepared by solvent diffusion method for epirubicin chemotherapy. Coll Surf B: Biointerf 71:19–26
   PubMed Web of Science ®Google Scholar
• Zipser B, Bradford JJ, Hollingsworth RI. (1998). Cholesterol and its derivatives, are the principal steroids isolated from the leech species Hirudo medicinalis. Comparat Biochem Physiol Part C: Pharmacol, Toxicol Endocrinol 120:269–82
   PubMed Web of Science ®Google Scholar